Reverse Medical secured European CE Mark approval for its UNO neurovascular embolization system, for obstructing blood flow in the blood vessels of the brain. The device also notched initial clinical use for intracranial specification.
Carestream Health said it landed 510(k) clearance from the FDA for its new Vue Motion mobile app for Apple and Samsung mobile device platforms.
The app gives physicians mobile access to X-ray exams using Apple’s iPhone 4 and iPad 2 devices, as well as the Galaxy Note and Galaxy S III devices made by Samsung.
A Mayo Clinic team and a group of seasoned technology entrepreneurs launched a new company called Ambient Clinical Analytics, aiming to provide real-time data and analyses for intensive care units and operating rooms.
The Medical Device Manufacturers Assn. and the Medical Imaging Technology Alliance tapped a pair of Capitol Hill veterans to lead their government affairs departments.
Clayton Hall, a former chief of staff for 3 representatives with 12 years on The Hill, was named vice president of government affairs at MDMA, the association said.
Pursuit Vascular is close to reaching a $1.6 million funding goal, having raised $1.57 million, according to a regulatory filing.
Minneapolis-based Pursuit Vascular is devleoping technology for reducing catheter infections, including the ClearGuard platform that’s designed to cut infections associated with hemodialysis catheters.
Evena Medical said it landed $5 million in a Series B funding round and inked a distribution deal in the Middle East and North Africa.
Silicon Valley-based Evena said it hopes the financing round will eventually reach $15 million. This tranche of the round comes from its new, unnamed distribution partner in 15 Middle Eastern and North African countries.
MedTech Idol is expanding its reach across the pond, opening up a competition for European medical device makers.
The contest, launched stateside last year, is produced by venture capital shop RCT Ventures. The competition exposes start-ups to a group of highly focused medical device investors, allowing the audience to choose the winner.
Paradigm Spine said it inked a $75 million credit agreement with PDL BioPharma.
Paradigm Spine, which makes spinal implants, said it will take the 1st $50 million in at closing, with another $25 million in milestone-based payments on the table.